三星医疗
(601567)
| 流通市值：494.50亿 | | | 总市值：500.27亿 |
| 流通股本：13.95亿 | | | 总股本：14.11亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 8,337,759,691.76 | 5,548,815,114.66 | 2,248,372,445.81 | 9,098,202,561.4 |
| 营业收入 | 8,337,759,691.76 | 5,548,815,114.66 | 2,248,372,445.81 | 9,098,202,561.4 |
| 二、营业总成本 | 6,923,060,196.62 | 4,672,390,393.07 | 1,942,265,271.77 | 8,045,106,754.45 |
| 营业成本 | 5,534,695,808.99 | 3,821,960,270.49 | 1,563,718,692.76 | 6,470,477,251.25 |
| 税金及附加 | 59,748,529.22 | 38,148,355.78 | 11,827,708.02 | 65,188,613.47 |
| 销售费用 | 509,939,356.23 | 336,158,871.12 | 139,244,349.83 | 647,580,910.87 |
| 管理费用 | 517,869,749.21 | 325,835,017.59 | 147,054,945.97 | 549,689,347.87 |
| 研发费用 | 319,474,410.37 | 210,022,708.01 | 79,357,579.39 | 327,023,160.08 |
| 财务费用 | -18,667,657.4 | -59,734,829.92 | 1,061,995.8 | -14,852,529.09 |
| 其中:利息费用 | 24,254,794.54 | 24,754,371.71 | 8,812,412.19 | 61,329,179.99 |
| 其中:利息收入 | 32,551,548.59 | 26,763,623.59 | 11,503,396.08 | 38,708,394.05 |
| 加:公允价值变动收益 | 88,886,123.15 | -395,152.36 | -2,477,344.83 | -107,480,691.55 |
| 加:投资收益 | 181,278,103.28 | 119,286,378.76 | 50,152,719.27 | 84,950,733.86 |
| 资产处置收益 | 241,481.43 | 245,863.43 | 3,761.68 | 188,961.9 |
| 资产减值损失(新) | 3,982,296.18 | 266,132.77 | -5,079,301.88 | -11,539,250 |
| 信用减值损失(新) | -41,164,872 | -27,067,852.91 | -23,856,774.2 | 13,160,917.07 |
| 其他收益 | 113,773,647.84 | 61,825,091.98 | 16,115,311.73 | 119,972,631.97 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 1,761,696,275.02 | 1,030,585,183.26 | 340,965,545.81 | 1,152,349,110.2 |
| 加:营业外收入 | 9,227,522.24 | 4,632,892.39 | 1,869,379.89 | 13,977,871.07 |
| 减:营业外支出 | 11,194,593.67 | 8,139,353.56 | 1,930,526.9 | 14,280,392.28 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 1,759,729,203.59 | 1,027,078,722.09 | 340,904,398.8 | 1,152,046,588.99 |
| 减:所得税费用 | 260,787,359.74 | 154,015,478.49 | 68,294,831.64 | 187,041,579.35 |
| 六、净利润 | 1,498,941,843.85 | 873,063,243.6 | 272,609,567.16 | 965,005,009.64 |
| 持续经营净利润 | 1,498,941,843.85 | 873,063,243.6 | 272,609,567.16 | 965,005,009.64 |
| 归属于母公司股东的净利润 | 1,489,328,029.59 | 869,708,954.73 | 269,516,681.64 | 948,115,535.82 |
| 少数股东损益 | 9,613,814.26 | 3,354,288.87 | 3,092,885.52 | 16,889,473.82 |
| (一)基本每股收益 | 1.05 | 0.62 | 0.19 | 0.67 |
| (二)稀释每股收益 | 1.05 | 0.62 | 0.19 | 0.67 |
| 八、其他综合收益 | 6,054,074.04 | 18,486,525.92 | 13,458,483.97 | 2,302,597.43 |
| 归属于母公司股东的其他综合收益 | 2,876,452.9 | 13,831,429.3 | 11,797,819.22 | 2,715,852.76 |
| 九、综合收益总额 | 1,504,995,917.89 | 891,549,769.52 | 286,068,051.13 | 967,307,607.07 |
| 归属于母公司股东的综合收益总额 | 1,492,204,482.49 | 883,540,384.03 | 281,314,500.86 | 950,831,388.58 |
| 归属于少数股东的综合收益总额 | 12,791,435.4 | 8,009,385.49 | 4,753,550.27 | 16,476,218.49 |
| 公告日期 | 2023-10-26 | 2023-08-24 | 2023-04-27 | 2023-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |